Digital health · 2026
From algorithms to clinical execution: A cross-validated knowledge atlas of AI-enabled precision care (2015-2025).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Boxiang, Yue Lau Lucy, Wang Kuan, Li Kejin, Li Boyang, Hong Zehao, Aldridge Richard J, Whitmore Elizabeth A, Zhao Zeliang, Chen Yi
Аннотация
OBJECTIVE: Artificial intelligence (AI)-driven precision medicine is moving beyond standalone prediction toward individualized treatment strategies built on multimodal evidence. Yet the field's rapid, interdisciplinary growth has produced a fragmented knowledge structure, while most bibliometric syntheses remain single-database and therefore vulnerable to coverage bias and unstable thematic inference. A cross-validated, implementation-oriented knowledge map is needed to clarify how AI innovations are converging on tailored treatment pathways.
METHODS: We established a dual-database cross-validation framework using the Web of Science Core Collection (WoSCC) and Scopus (2015-2025). After parallel screening, preprocessing, and standardized metadata/keyword normalization, 810 WoSCC records and 999 Scopus records were analyzed independently. Science-mapping was performed across publication dynamics, collaboration networks, journal/reference co-citation structures, keyword clustering, burst detection, and longitudinal thematic evolution, followed by explicit cross-database consistency checks.
RESULTS: Across 1809 publications, both databases showed concordant structural patterns: the United States and China formed the central global hubs, while institution-level networks were more stable and coherent than author-level clusters, led by Harvard Medical School, Stanford University, and major Chinese universities/academies. The field evolved in stages from feasibility and data-source expansion to multimodal/multi-omics integration, then toward mechanism-informed interpretability and clinically oriented stratification. Recent frontiers converge on three axes: biologically grounded multimodal inference, explainable AI constrained by biological priors, and deployable decision systems integrating imaging AI, hybrid decision support, and emerging LLM-agent paradigms.
CONCLUSION: This dual-database, cross-validated atlas delineates a robust trajectory toward clinically executable, AI-enabled personalized medicine. By linking thematic evolution to deployability and interpretability, it provides a transferable framework to prioritize patient stratification, therapy optimization, and workflow-integrated decision support in real-world settings.
METHODS: We established a dual-database cross-validation framework using the Web of Science Core Collection (WoSCC) and Scopus (2015-2025). After parallel screening, preprocessing, and standardized metadata/keyword normalization, 810 WoSCC records and 999 Scopus records were analyzed independently. Science-mapping was performed across publication dynamics, collaboration networks, journal/reference co-citation structures, keyword clustering, burst detection, and longitudinal thematic evolution, followed by explicit cross-database consistency checks.
RESULTS: Across 1809 publications, both databases showed concordant structural patterns: the United States and China formed the central global hubs, while institution-level networks were more stable and coherent than author-level clusters, led by Harvard Medical School, Stanford University, and major Chinese universities/academies. The field evolved in stages from feasibility and data-source expansion to multimodal/multi-omics integration, then toward mechanism-informed interpretability and clinically oriented stratification. Recent frontiers converge on three axes: biologically grounded multimodal inference, explainable AI constrained by biological priors, and deployable decision systems integrating imaging AI, hybrid decision support, and emerging LLM-agent paradigms.
CONCLUSION: This dual-database, cross-validated atlas delineates a robust trajectory toward clinically executable, AI-enabled personalized medicine. By linking thematic evolution to deployability and interpretability, it provides a transferable framework to prioritize patient stratification, therapy optimization, and workflow-integrated decision support in real-world settings.